Plasmodium

New Oxford malaria vaccine shows strong safety and effectiveness

Although it may seem like all we talk about are the COVID-19 vaccines, there is a new malaria vaccine developed by Oxford University that has shown a strong effectiveness and safety profile in phase 1/2b clinical trials. Control of malaria has been a goal of scientists for a long time, a potential malaria vaccine is something that should be celebrated widely.

If all goes well, the Oxford malaria vaccine could be approved by late 2023, saving children in many parts of the world from this scourge.

A new paper has been published that provides details of the clinical trial, which I will review below.

Malaria vaccine clinical trials – a breakthrough in stopping a deadly disease

Although it may seem like all we talk about are the COVID-19 vaccines, but there’s more going on out there. One is a new breakthrough malaria vaccine that may bring an end to this scourge.

We are still a few years away from this vaccine being widely available, but since control of malaria has been a goal of scientists for a long time, a potential malaria vaccine is something that should be celebrated widely.